Europe Mobile Health Market Size

Europe mHealth Market Analysis

The Europe Mobile Health Market size is estimated at USD 27.61 billion in 2024, and is expected to reach USD 85.72 billion by 2029, growing at a CAGR of 25.43% during the forecast period (2024-2029).

Thus, COVID-19 has impacted positively the demand for the mobile health market in Europe, and it is expected to increase with time. According to the article 'The European digital health revolution in the wake of COVID-19' published in April 2021, the European Commission proposed the EU4Health program as part of a COVID-19 recovery response program. The initiative aims to raise EUR 5.1 billion for the digital transformation of the European health sector and ensure preparedness for future cross-border health threats. Thus, increasing investments by European governments toward the digital transformation of healthcare will drive market growth over the study period. Remote patient monitoring (RPM) is a one-to-many telemedicine solution that can rapidly increase healthcare system capacities. MedTech company COVID-19 Telemedicine ApS provides COVID-19 clinical protocols for remote screening and monitoring of patients. The European Commission-funded project COVID-19 Telemedicine started in August 2020, will take the solution to the next level of technological readiness. In addition to reducing staff exposure to contagions, the number of emergency department visits and hospitalizations, as well as the duration of hospital stays are also expected to reduce. The remote patient monitoring (RPM solution provides comfort to anxious patients in home isolation and quarantine. The automated triage makes it a highly scalable and resource-efficient infectious disease management tool for COVID-19 and future pandemics. Such government-funded projects are expected to positively impact market growth. Thus, the abovementioned factors are likely to increase the market growth.

mHealth or Mobile Health is the use of mobile and wireless technologies to support the achievement of health objectives. The most common application of mHealth is the use of mobile devices to educate consumers about preventive healthcare services. However, mHealth is also used for disease surveillance, treatment support, epidemic outbreak tracking, and chronic disease management. Factors such as growing burden of chronic diseases, advancements in technology, rising awareness about the health of the population, and initiatives taken by the government are driving the growth of the market segment over the forecast period. Additionally, European Union is promoting a program titled 'Promoting a trusted mHealth label in Europe: uptake of Technical specifications for 'Quality and Reliability of Health and Wellness Apps' with the aim to prioritize digital tools for citizen empowerment and for person-centered care whose submission date was in September 2021. such initiatives taken by the government are also driving the growth of the market. The market segment growth has boosted the launch of new products incorporated with advanced technology such as Artificial Intelligence etc. For Instance, in April 2021, TytoCare the healthcare industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, has launched in Italy, enabling the adoption of its mhealth solution throughout the country. The launch is taking place via a partnership with Multimed. Additionally, in March 2021, Spanish mobile network Yoigo also launched a mhealth service named Doctor Go. The Doctor Go telemedicine service offers video consultations with family doctors and specialists, as well as telepharmacy services for electronic prescriptions and the delivery of medicines. Similarly, in May 2021, Royal Philips launched the new Philips Interventional Applications Platform, IntraSight Mobile that brings together imaging and physiology applications on a mobile system for coronary and peripheral artery disease therapy in Europe. Furthermore, the support from the government by providing grants is also driving the growth of the market over time. For Instance, in May 2021, the United Kingdom health tech company my mhealth, and collaborators were awarded EUR 2.5 million Eurostars Grants for the development of their project named CUOREMA. The CUOREMA project will focus on developing a new, patient-centered cardiac rehabilitation support system. Thus, owing to the abovementioned factors, the mhealth market is expected to project growth over the forecast period.

However, data security issues and stringent regulatory policies for mHealth applications are likely to hinder the market growth.